Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001225208-14-015513
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-23 18:11:27
Reporting Period:
2014-06-20
Filing Date:
2014-06-23
Accepted Time:
2014-06-23 18:11:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1183765 Threshold Pharmaceuticals Inc THLD Pharmaceutical Preparations (2834) 943409596
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339801 E David Sweet 755 Page Mill Road, Suite A-200
Palo Alto CA 94304-1005
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-06-20 3,960 $4.01 0 No 4 S Indirect By Ltd Partnership (SHAI)
Common Stock Disposition 2014-06-20 10,028 $4.01 0 No 4 S Indirect By Ltd Partnership (SHQP)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Ltd Partnership (SHAI)
No 4 S Indirect By Ltd Partnership (SHQP)
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,525,005 Indirect By Ltd Partnership (SHV)
Common Stock 38,061 Indirect By Profit Sharing Plan Trust
Common Stock 10,948 Indirect By Trust
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.0050 to $4.0150, inclusive. The reporting person undertakes to provide Threshold Pharmaceuticals, Inc., any security holder of Threshold Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Shares sold by Sutter Hill Entrepreneurs Fund (AI), L.P. The reporting person is a Managing Director of the General Partner of Sutter Hill Entrepreneurs Fund (AI), L.P. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  3. Shares sold by Sutter Hill Entrepreneurs Fund (QP), L.P. The reporting person is a Managing Director of the General Partner of Sutter Hill Entrepreneurs Fund (QP), L.P. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  4. Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  5. Shares held by SHV Profit Sharing Plan, a retirement trust, for the benefit of the reporting person.
  6. Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.